Future Outlook of the Implantable Neurostimulation Devices Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the implantable neurostimulation devices market size evolved in recent years?
The implantable neurostimulation devices market has expanded rapidly, expected to grow from $8.68 billion in 2024 to $9.64 billion in 2025 at a CAGR of 11.1%. The growth in past years has been driven by increasing demand for non-pharmacological treatments, rising preference for minimally invasive procedures, an aging population, the prevalence of psychiatric disorders, and the growing incidence of chronic diseases.
What are the predictions for the implantable neurostimulation devices market size in the coming years?
The implantable neurostimulation devices market is anticipated to grow rapidly, reaching $14.53 billion by 2029 at a CAGR of 10.8%. Growth drivers include the rising prevalence of neurological disorders, lifestyle-related diseases, increasing awareness, spinal cord injuries, and growing healthcare expenditure. Key trends include advancements in neurostimulation technologies, sensing technology, closed-loop systems, integration of wireless technology, and continuous innovation in product design.
Get your implantable neurostimulation devices market report here!
What key factors are fueling the growth of the implantable neurostimulation devices market?
The increasing prevalence of neurological disorders is expected to drive the growth of the implantable neurostimulation device market. Neurological disorders affect the nervous system, causing symptoms like paralysis, seizures, and cognitive issues. Factors like high blood pressure, trauma, and developmental abnormalities contribute to the rising detection rates. Implantable neurostimulation devices are used to modulate nerve activity and alleviate symptoms when other treatments fail. For example, in 2024, the Alzheimer’s Association estimated that 6.9 million Americans aged 65 and older are living with Alzheimer’s, and this number is projected to rise to 12.7 million by 2050. Hence, the growing prevalence of neurological disorders will propel the market.
How is the global implantable neurostimulation devices market divided into key segments?
The implantable neurostimulation devicesmarket covered in this report is segmented –
1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices
2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators
3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression
6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp
Who are the key firms paving the way for growth in the implantable neurostimulation devices market?
Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC
Which trends are expected to transform the implantable neurostimulation devices market?
Leading firms in the implantable neurostimulation devices industry are making strides in creating cutting-edge products, such as spinal cord stimulation (SCS) systems, aimed at managing chronic pain. An SCS system, a type of medical device, leverages electric shocks to manipulate neural activity in the spinal cord, relieving long-term pain and improving patient lives, especially when conventional treatments fail. For example, Abbott, a US medical device firm, revealed in December 2022 that the U.S. Food and Drug Administration (FDA) had approved their Eterna spinal cord stimulation (SCS) system. The Eterna SCS stands as the smallest implantable, rechargeable device of this type on the market, designed for optimal daily comfort. It incorporates Abbott’s unique BurstDR stimulation technology, replicating the brain’s natural firing patterns for enhanced pain alleviation, and is preferred by 87% of users over the usual tingling stimulation. The Eterna system guarantees user-friendliness with its minimal recharging needs, demanding just around five annual recharges owing to its Xtend energy technology. It accommodates comprehensive body MRI scans via TotalScan technology and can adapt to future technological progress without needing replacement. Additionally, Abbott provides mobile app integration, allowing users to monitor the device’s battery life and charging status in real time on their iPhones.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19520
What regions are contributing significantly to the growth of the implantable neurostimulation devices market?
North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Implantable Infusion Pumps Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Implantable Loop Recorders Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-loop-recorders-global-market-report
Implantable Biomaterials Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-biomaterials-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
